Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Shristi Bhattarai"'
Autor:
Shristi Bhattarai, Manali Rupji, Hsueh-ping Chao, Qi Xu, Geetanjali Saini, Padmashree Rida, Mohammed A. Aleskandarany, Andrew R. Green, Ian O. Ellis, Emiel A. Janssen, Kristin Jonsdottir, Emad Rakha, Jeanne Kowalski, Ritu Aneja
Publikováno v:
BJC Reports, Vol 2, Iss 1, Pp 1-10 (2024)
Abstract Background Ki67 index (KI) and mitotic index (MI) are proliferation markers with established prognostic value in breast carcinomas. While KI is evaluated immunohistochemically and reported as a percentage, MI is determined visually and refle
Externí odkaz:
https://doaj.org/article/8feb79c71f7142a48c824535a1a38430
Autor:
Timothy B. Fisher, Geetanjali Saini, T. S. Rekha, Jayashree Krishnamurthy, Shristi Bhattarai, Grace Callagy, Mark Webber, Emiel A. M. Janssen, Jun Kong, Ritu Aneja
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-13 (2024)
Abstract Background Pathological complete response (pCR) is associated with favorable prognosis in patients with triple-negative breast cancer (TNBC). However, only 30–40% of TNBC patients treated with neoadjuvant chemotherapy (NAC) show pCR, while
Externí odkaz:
https://doaj.org/article/9bc17a375e25468388fa164cf619ad20
Autor:
Sofia Awan, Geetanjali Saini, Keerthi Gogineni, Justin M. Luningham, Lindsay J. Collin, Shristi Bhattarai, Ritu Aneja, Courtney P. Williams
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 17331-17339 (2023)
Abstract Background Little is known regarding the association between insurance status and treatment delays in women with breast cancer and whether this association varies by neighborhood socioeconomic deprivation status. Methods In this cohort study
Externí odkaz:
https://doaj.org/article/321aeb94adfe45059ad183d04694b03d
Autor:
Chakravarthy Garlapati, Shriya Joshi, Shristi Bhattarai, Jayashree Krishnamurthy, Ravi Chakra Turaga, Thi Nguyen, Xiaoxian Li, Ritu Aneja
Publikováno v:
Cell Death and Disease, Vol 14, Iss 1, Pp 1-13 (2023)
Abstract Protein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. The mitotic kinases polo-like kinase 1 (PLK1) and Aurora B (AURKB) phosphorylate survivin, an inh
Externí odkaz:
https://doaj.org/article/f343c4b80d5e42a28ab33ee33cdc19cd
Autor:
Shristi Bhattarai, Geetanjali Saini, Hongxiao Li, Gaurav Seth, Timothy B. Fisher, Emiel A. M. Janssen, Umay Kiraz, Jun Kong, Ritu Aneja
Publikováno v:
Diagnostics, Vol 14, Iss 1, p 74 (2023)
Background: Neoadjuvant chemotherapy (NAC) is the standard treatment for early-stage triple negative breast cancer (TNBC). The primary endpoint of NAC is a pathological complete response (pCR). NAC results in pCR in only 30–40% of TNBC patients. Tu
Externí odkaz:
https://doaj.org/article/76ffd498081d4fdea5f0b9520970ba1e
Autor:
Mousumi Roy, Fusheng Wang, George Teodoro, Shristi Bhattarai, Mahak Bhargava, T. Subbanna Rekha, Ritu Aneja, Jun Kong
Publikováno v:
Journal of Pathology Informatics, Vol 14, Iss , Pp 100311- (2023)
For routine pathology diagnosis and imaging-based biomedical research, Whole-slide image (WSI) analyses have been largely limited to a 2D tissue image space. For a more definitive tissue representation to support fine-resolution spatial and integrati
Externí odkaz:
https://doaj.org/article/507ff5542f894b7f80bf158b61c3d903
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 1129-1140 (2021)
Externí odkaz:
https://doaj.org/article/ffd96f07f349440c96f82f95ba1c77a6
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-11 (2020)
Abstract Based on the androgen receptor (AR) expression, triple-negative breast cancer (TNBC) can be subdivided into AR-positive TNBC and AR-negative TNBC, also known as quadruple-negative breast cancer (QNBC). QNBC characterization and treatment is
Externí odkaz:
https://doaj.org/article/a916b97063cf4804ae83baaa8f9e2070
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 233-237 (2020)
Externí odkaz:
https://doaj.org/article/a03fc74dc39347e5864892210b52198c
Autor:
Sergey Klimov, Yue Xue, Arkadiusz Gertych, Rondell P. Graham, Yi Jiang, Shristi Bhattarai, Stephen J. Pandol, Emad A. Rakha, Michelle D. Reid, Ritu Aneja
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
BackgroundThe prognosis of patients with pancreatic neuroendocrine tumors (PanNET), the second most common type of pancreatic cancer, varies significantly, and up to 15% of patients develop metastasis. Although certain morphological characteristics o
Externí odkaz:
https://doaj.org/article/e4be2f92cd554d59aefb1a5439d988b3